BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6546051)

  • 1. Normal donor monitoring standards.
    Menitove JE; Grindon AJ; Nusbacher J; Price TH; Aster RH
    J Clin Apher; 1983; 1(3):124-9. PubMed ID: 6546051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Side effects of thrombocytapheresis and leukocytapheresis in healthy donors].
    Höcker P; Wagner A; Puffer G; Michl U
    Beitr Infusionther Klin Ernahr; 1987; 18():205-9. PubMed ID: 3439974
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular depletion by apheresis.
    Strauss RG; Huestis DW; Wright DG; Hester JP
    J Clin Apher; 1983; 1(3):158-65. PubMed ID: 6546054
    [No Abstract]   [Full Text] [Related]  

  • 4. [The apheresis: plasmapheresis, plateletpheresis, leukapheresis. Physiopathology of the donor (author's transl)].
    Avanzi G
    Pathologica; 1978; 70(1007-1008):467-80. PubMed ID: 370755
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple pheresis - effect on the donor.
    Ho W
    Prog Clin Biol Res; 1981; 65():91-9. PubMed ID: 7330074
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and laboratory effects on donors of intermittent-flow centrifugation platelet-leukapheresis performed with hydroxyethyl starch and citrate.
    Strauss RG; Koepke JA; Maguire LC; Thompson JS
    Clin Lab Haematol; 1980; 2(1):1-11. PubMed ID: 6155239
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adverse effects of hemapheresis].
    Bláha M; Jebavý L; Siroký O; Malý J; Pecka M
    Vnitr Lek; 1989 Oct; 35(10):972-81. PubMed ID: 2617884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health risk of leukapheresis donors.
    Sandler SG; Nusbacher J
    Haematologia (Budap); 1982; 15(1):57-69. PubMed ID: 6180961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects in donors and patients subjected to hemapheresis.
    Huestis DW
    J Clin Apher; 1984; 2(1):81-90. PubMed ID: 6536662
    [No Abstract]   [Full Text] [Related]  

  • 10. Health risks to cytapheresis donors.
    Westphal RG
    Clin Haematol; 1984 Feb; 13(1):289-301. PubMed ID: 6202448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic reactions in healthy plateletpheresis donors caused by sensitization to ethylene oxide gas.
    Leitman SF; Boltansky H; Alter HJ; Pearson FC; Kaliner MA
    N Engl J Med; 1986 Nov; 315(19):1192-6. PubMed ID: 2429183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side-effects of cytapheresis with cell separators.
    Höcker P; Wagner A
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 4():31-5. PubMed ID: 3679528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat plateletpheresis--the effects on the donor and the yield.
    Rock G; Tittley P; Sternbach M; Buskard N; Schroeder M
    Prog Clin Biol Res; 1990; 337():27-30. PubMed ID: 2352986
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemolysis following cytapheresis. 2 cases].
    Schooneman F; Janot C; Streiff F
    Nouv Presse Med; 1980 Feb; 9(8):540. PubMed ID: 7367294
    [No Abstract]   [Full Text] [Related]  

  • 15. Practical considerations for planning a therapeutic apheresis procedure.
    Shelat SG
    Am J Med; 2010 Sep; 123(9):777-84. PubMed ID: 20541168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates of vaso-vagal reactions among first time teenaged whole blood, double red cell, and plateletpheresis donors.
    Reiss RF; Harkin R; Lessig M; Mascari J
    Ann Clin Lab Sci; 2009; 39(2):138-43. PubMed ID: 19429799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The International Apheresis Registry: results of 1983 second pilot.
    Malchesky PS; Skibinski CI; Williams GW; Nosé Y
    Artif Organs; 1987 Apr; 11(2):173-82. PubMed ID: 3593045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety and discomfort of the donors during thrombocytapheresis with the cell separator. A psychological study].
    Basler HD; Steinfelder C; Hartnack U; Kretschmer V
    Beitr Infusionther Klin Ernahr; 1987; 18():199-204. PubMed ID: 3439973
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the serum biochemical indicators in healthy blood donors during cytapheresis].
    Shtereva T; Gekova K; Mikhalev A; Arsov Ts; Dimitrov D
    Vutr Boles; 1988; 27(3):94-6. PubMed ID: 3206910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.